These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12818746)

  • 1. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM; van Vliet RC; van de Ven WP
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belgium: risk adjustment and financial responsibility in a centralised system.
    Schokkaert E; Van de Voorde C
    Health Policy; 2003 Jul; 65(1):5-19. PubMed ID: 12818742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk adjustment and risk sharing: the Israeli experience.
    Shmueli A; Chernichovsky D; Zmora I
    Health Policy; 2003 Jul; 65(1):37-48. PubMed ID: 12818744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needs for further improvement: risk adjustment in the German health insurance system.
    Buchner F; Wasem J
    Health Policy; 2003 Jul; 65(1):21-35. PubMed ID: 12818743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    J Health Econ; 2001 Mar; 20(2):147-68. PubMed ID: 11252368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growing importance of capitation in Switzerland.
    Beck K
    Health Care Manag Sci; 2000 Feb; 3(2):111-9. PubMed ID: 10780279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adjusted capitation. The Israeli experience.
    Shmueli A; Chinitz D
    Eur J Public Health; 2001 Jun; 11(2):182-4. PubMed ID: 11420807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has solidarity survived? A comparative analysis of the effect of social health insurance reform in four European countries.
    Maarse H; Paulus A
    J Health Polit Policy Law; 2003 Aug; 28(4):585-614. PubMed ID: 12956517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of the impact of reimbursement schemes on health plan choice.
    Keeler EB; Carter G; Newhouse JP
    J Health Econ; 1998 Jun; 17(3):297-320. PubMed ID: 10180920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cream-skimming, incentives for efficiency and payment system.
    Barros PP
    J Health Econ; 2003 May; 22(3):419-43. PubMed ID: 12683960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adjustment and the fear of markets: the case of Belgium.
    Schokkaert E; Van de Voorde C
    Health Care Manag Sci; 2000 Feb; 3(2):121-30. PubMed ID: 10780280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation and risk selection in deregulated social health insurance.
    Lehmann H; Zweifel P
    J Health Econ; 2004 Sep; 23(5):997-1012. PubMed ID: 15353190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reforming the Israeli health system: findings of a 3-year evaluation.
    Gross R; Rosen B; Shirom A
    Health Policy; 2001 Apr; 56(1):1-20. PubMed ID: 11230905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of diagnosis-based risk adjustment measures in a population of sick Australians.
    Duckett SJ; Agius PA
    Aust N Z J Public Health; 2002 Dec; 26(6):500-7. PubMed ID: 12530791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-minimizing risk adjustment.
    Shen Y; Ellis RP
    J Health Econ; 2002 May; 21(3):515-30. PubMed ID: 12022271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.